Your browser doesn't support javascript.
loading
Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras.
Saá, Paula; Fink, Rebecca V; Dawar, Hina; Di Germanio, Clara; Montalvo, Leilani; Wright, David J; Krysztof, David E; Kleinman, Steven H; Nester, Theresa; Kessler, Debra A; Townsend, Rebecca L; Spencer, Bryan R; Kamel, Hany; Vannoy, Jackie; Busch, Michael P; Stramer, Susan L; Stone, Mars; Norris, Philip J.
Afiliación
  • Saá P; Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
  • Fink RV; Westat, Rockville, Maryland, USA.
  • Dawar H; Vitalant Research Institute, San Francisco, California, USA.
  • Di Germanio C; Vitalant Research Institute, San Francisco, California, USA.
  • Montalvo L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
  • Wright DJ; Vitalant Research Institute, San Francisco, California, USA.
  • Krysztof DE; Westat, Rockville, Maryland, USA.
  • Kleinman SH; Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
  • Nester T; University of British Columbia, Victoria, British Columbia, Canada.
  • Kessler DA; Bloodworks Northwest, Seattle, Washington, USA.
  • Townsend RL; New York Blood Center Enterprises, New York, New York, USA.
  • Spencer BR; Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
  • Kamel H; Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
  • Vannoy J; Vitalant, Scottsdale, Arizona, USA.
  • Busch MP; Vitalant, Scottsdale, Arizona, USA.
  • Stramer SL; Vitalant Research Institute, San Francisco, California, USA.
  • Stone M; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
  • Norris PJ; Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
Open Forum Infect Dis ; 10(5): ofad253, 2023 May.
Article en En | MEDLINE | ID: mdl-37250174
ABSTRACT
Presymptomatic plasma samples from 1596 donors reporting coronavirus disease 2019 infection or symptoms after blood donation were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and anti-S and anti-N antibodies. Prior infection and vaccination both protected from developing SARS-CoV-2 RNAemia and from symptomatic infection. RNAemia rates did not differ in the Delta and Omicron variant eras.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos